Nutraceuticals

The gut-brain axis: exploring its role in health care

The gut-brain axis: exploring its role in health care

In the intestine, gut distension and nutrients are detected by mechanoreceptors and chemoreceptors, respectively. The activation of these receptors sends an afferent nervous message to the hypothalamus in the brain. In turn, the hypothalamus controls the glucose entry in tissues, and thus glycemia.

12-HETE enterosyne: new insights into glucose metabolism

12-HETE enterosyne: new insights into glucose metabolism

The discovery of intestinal actors, such as enterosynes, able to modulate the ENS-induced duodenal contraction is an innovative approach. Among all the intestinal factors, the understanding of the role of gut microbes in controlling glycaemia remains a major target. For instance, we researched and demonstrated how the modulation of gut microbiota by prebiotics could permit the identification of novel enterosynes.

Glucose: a key player in gut motility and metabolic regulation

Glucose: a key player in gut motility and metabolic regulation

Targeting the enteric nervous system that controls gut motility is now considered as an innovative therapeutic way in T2D to limit intestinal glucose absorption and restore the gut‐brain axis to improve insulin sensitivity. So far, little is known about the role of glucose on duodenal contraction in fasted and fed states in normal and diabetic conditions.

Gut microbiota: a key player in gut-brain communication

Gut microbiota: a key player in gut-brain communication

Currently, the gut is considered a primary site for the development of pathologies that modify brain functions such as neurodegenerative (Parkinson’s, Alzheimer’s, etc.) and metabolic (type 2 diabetes, obesity, etc.) disorders. Deciphering the mode of interaction between microbiota and the brain is a real original option to prevent (and maybe treat in the future) the establishment of gut-brain disfunctions and associated pathologies.

Camu Camu extract: health benefits against metabolic disorders

Camu Camu extract: health benefits against metabolic disorders

The Amazonian forests are home to a shrub, the camu-camu, whose fruit could be of great help in the fight against obesity and metabolic diseases. This is described in our latest study published with the A-Mansia R&D team in the journal Metabolites.

Enteric nervous system : Galanin’s role in gut-brain axis

Enteric nervous system : Galanin’s role in gut-brain axis

The enteric nervous system (ENS) plays a key role in controlling the gut-brain axis under normal and pathological conditions, such as type 2 diabetes. The discovery of intestinal actors, such as enterosynes, able to modulate the ENS-induced duodenal contraction is considered a pioneering approach.

Research

Categorie

Archives

Functional ingredients: from plausibility to proof

The functional food market is no longer a niche. The global functional foods market was estimated at $332 billion in 2024 and is expected to grow to $638 billion by 2034, at a CAGR of 6.9%. In North America alone, more than 65% of consumers reported in 2024 actively...

Gut motility: the hidden role of the enteric nervous system

TAKE HOME MESSAGES :  The ENS orchestrates gut motility through a complex balance of neural circuits and neurotransmitters. Disruptions in gut motility can trigger systemic metabolic imbalances, contributing to hyperglycemia and insulin resistance. ENS dysfunction is...